179 related articles for article (PubMed ID: 22791787)
1. Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study.
Sheppard JP; Singh S; Fletcher K; McManus RJ; Mant J
BMJ; 2012 Jul; 345():e4535. PubMed ID: 22791787
[TBL] [Abstract][Full Text] [Related]
2. Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.
Mohammed MA; El Sayed C; Marshall T
Med Decis Making; 2012; 32(3):498-506. PubMed ID: 22357626
[TBL] [Abstract][Full Text] [Related]
3. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
Fleetcroft R; Schofield P; Ashworth M
BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
[TBL] [Abstract][Full Text] [Related]
4. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare.
Hyun KK; Redfern J; Patel A; Peiris D; Brieger D; Sullivan D; Harris M; Usherwood T; MacMahon S; Lyford M; Woodward M
Heart; 2017 Apr; 103(7):492-498. PubMed ID: 28249996
[TBL] [Abstract][Full Text] [Related]
5. Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.
O'Keeffe AG; Petersen I; Nazareth I
BMJ Open; 2015 Mar; 5(3):e007207. PubMed ID: 25748418
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
7. Missed opportunities in prevention of cardiovascular disease in primary care: a cross-sectional study.
Sheppard JP; Fletcher K; McManus RJ; Mant J
Br J Gen Pract; 2014 Jan; 64(618):e38-46. PubMed ID: 24567581
[TBL] [Abstract][Full Text] [Related]
8. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.
Dorsch MP; Lester CA; Ding Y; Joseph M; Brook RD
J Am Heart Assoc; 2019 Nov; 8(22):e014709. PubMed ID: 31707943
[TBL] [Abstract][Full Text] [Related]
9. Differences in Cardiovascular Care Between Adults With and Without Opioid Prescriptions in the United States.
Feng Z; Williams D; Ladapo JA
J Am Heart Assoc; 2020 Jun; 9(11):e015961. PubMed ID: 32458701
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
[TBL] [Abstract][Full Text] [Related]
11. Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.
Finnikin S; Ryan R; Marshall T
BMJ Open; 2016 Nov; 6(11):e013120. PubMed ID: 27856481
[TBL] [Abstract][Full Text] [Related]
12. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
13. Statin prescribing for primary prevention of cardiovascular disease: a cross-sectional, observational study.
Homer K; Boomla K; Hull S; Dostal I; Mathur R; Robson J
Br J Gen Pract; 2015 Aug; 65(637):e538-44. PubMed ID: 26212850
[TBL] [Abstract][Full Text] [Related]
14. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
[TBL] [Abstract][Full Text] [Related]
15. Age-Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011-2018.
Rhee TG; Kumar M; Ross JS; Coll PP
J Am Geriatr Soc; 2021 May; 69(5):1272-1282. PubMed ID: 33598936
[TBL] [Abstract][Full Text] [Related]
16. Targeted case finding in the prevention of cardiovascular disease: a stepped wedge cluster randomised controlled trial.
Hemming K; Ryan R; Gill P; Westerby P; Jolly K; Marshall T
Br J Gen Pract; 2016 Oct; 66(651):e758-67. PubMed ID: 27528707
[TBL] [Abstract][Full Text] [Related]
17. Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.
Brown F; Singer A; Katz A; Konrad G
Can Fam Physician; 2017 Nov; 63(11):e495-e503. PubMed ID: 29138175
[TBL] [Abstract][Full Text] [Related]
18. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in the Use of Statins in Community Practice.
Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
[TBL] [Abstract][Full Text] [Related]
20. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
